Liminatus Pharma, Inc.

Q: Jun 30 2026

Q: Mar 31 2026

FY: Dec 31 2025

Q: Sep 30 2025

Q: Jun 30 2025

Q: Jun 30 2025

Q: Mar 31 2025

Q: Mar 31 2025

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Submission of Matters to a Vote of Security Holders

Other Events

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Entry into a Material Definitive Agreement

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Regulation FD Disclosure

Entry into a Material Definitive Agreement

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Other Events

Regulation FD Disclosure

Registration (IPO) statement under Securities Act of 1933

Rule 506(b) provides a "safer harbor" for a private offering

Prospectus Supplement for Primary Offering

Prospectus Supplement with Pricing Information

Notice of Effectiveness

Registration (IPO) statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Amended Initial Registration Statement

Registration (IPO) statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Post-effective amendment to a registration statement

Post-effective amendment to a registration statement

Post-effective amendment to a registration statement

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration statement under Securities Act of 1933 (amendment)

Registration statement under Securities Act of 1933 (amendment)

Registration statement under Securities Act of 1933 (amendment)

Definitive Proxy Statement

Preliminary Proxy Statement

Samda Biolab Co., Ltd.

Kim Chris; Valetudo Therapeutics LLC

Valetudo Therapeutics LLC

Kim Chris; Valetudo Therapeutics LLC

Ewon Comfortech Co., Ltd.

Ewon Comfortech Co., Ltd.

INTRACOASTAL CAPITAL, LLC

Iris Acquisition Holdings LLC

Lemons II Philip Wayne

Baek Richard JaiHwan

KH Feelux Co., Ltd

KH Feelux Co., Ltd

Ewon Comfortech Co., Ltd.

Nongae Apple Association 1st

Red Peony Association 1st

Kim Chris; Valetudo Therapeutics LLC

Iris Acquisition Holdings LLC

Valetudo Therapeutics LLC

Lee Eun Sook

Lee Sang-Jin

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Financial Statements and Exhibits

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC